(Q34941162)

5 August 2017

title

Impact of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of ondansetron and dexamethasone (English)

1 reference

5 August 2017

1 reference

1 reference

Brendan Johnson

1

1 reference

5 August 2017

Laurel Adams

2

1 reference

5 August 2017

Emily Lu

3

1 reference

5 August 2017

Ke Zhang

4

1 reference

5 August 2017

Peter Lebowitz

5

1 reference

5 August 2017

Christian Lates

6

1 reference

5 August 2017

Robert Blum

7

1 reference

5 August 2017

publication date

10 February 2009

1 reference

Supportive Care in Cancer

5 August 2017

published in

1 reference

5 August 2017

volume

17

1 reference

5 August 2017

issue

9

1 reference

5 August 2017

page(s)

1177-1185

1 reference

Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Genetic contribution to variable human CYP3A-mediated metabolism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Proposal for classifying the acute emetogenicity of cancer chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2726912

In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone

26 October 2018

1 reference

12 December 2020

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics

1 reference

12 December 2020

Dose-dependent pharmacokinetics of dexamethasone

1 reference

12 December 2020

Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans

1 reference

12 December 2020

Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation

1 reference

12 December 2020

Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials

1 reference

12 December 2020

10.1007/S00520-008-0571-5

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference